{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:14:19Z","timestamp":1789064059408,"version":"build-2803163510"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230477-4\"><jats:title>Importance<\/jats:title><jats:p>Prior research suggests significant social value associated with increased longevity due to preventing and treating cancer. Other social costs associated with cancer, such as unemployment, public medical spending, and public assistance, may also be sizable.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230477-5\"><jats:title>Objective<\/jats:title><jats:p>To examine whether a cancer history is associated with receipt of disability insurance, income, employment, and medical spending.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230477-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cross-sectional study used data from the Medical Expenditure Panel Study (MEPS) (2010-2016) for a nationally representative sample of US adults aged 50 to 79 years. Data were analyzed from December 2021 to March 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230477-7\"><jats:title>Exposure<\/jats:title><jats:p>Cancer history.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230477-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcomes were employment, public assistance receipt, disability, and medical expenditures. Variables for race, ethnicity, and age were used as controls. A series of multivariate regression models were used to assess the immediate and 2-year association of a cancer history with disability, income, employment, and medical spending.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230477-9\"><jats:title>Results<\/jats:title><jats:p>Of 39\u202f439 unique MEPS respondents included in the study, 52% were female, and the mean (SD) age was 61.44 (8.32) years; 12% of respondents had a history of cancer. Individuals with a cancer history who were aged 50 to 64 years were 9.80 (95% CI, 7.35-12.25) percentage points more likely to have a work-limiting disability and were 9.08 (95% CI, 6.22-11.94) percentage points less likely to be employed compared with individuals in the same age group without a history of cancer. Nationally, cancer accounted for 505\u202f768 fewer employed individuals in the population aged 50 to 64 years. A cancer history was also associated with an increase of $2722 (95% CI, $2131-$3313) in medical spending, $6460 (95% CI, $5254-$7667) in public medical spending, and $515 (95% CI, $337-$692) in other public assistance spending.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi230477-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cross-sectional study, a history of cancer was associated with increased likelihood of disability, higher medical spending, and decreased likelihood of employment. These findings suggest there may be gains beyond increased longevity if cancer can be detected and treated earlier.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.15823","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:31:42Z","timestamp":1685115102000},"page":"e2315823","source":"Crossref","is-referenced-by-count":8,"title":["Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses"],"prefix":"10.1001","volume":"6","author":[{"given":"David C.","family":"Grabowski","sequence":"first","affiliation":[{"name":"Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuraag R.","family":"Kansal","sequence":"additional","affiliation":[{"name":"GRAIL, LLC, Menlo Park, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana P.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Alfred Mann School of Pharmacy and Sol Price School of Public Policy, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius N.","family":"Lakdawalla","sequence":"additional","affiliation":[{"name":"Alfred Mann School of Pharmacy and Sol Price School of Public Policy, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"3","key":"zoi230477r1","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s11357-021-00366-6","article-title":"50 Years of the \u201cwar on cancer\u201d: lessons for public health and geroscience.","volume":"43","author":"Farrelly","year":"2021","journal-title":"Geroscience"},{"issue":"10","key":"zoi230477r3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.6004\/jnccn.2020.7574","article-title":"Association between clinical value and financial cost of cancer treatments: a cross-sectional analysis.","volume":"18","author":"Mitchell","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"zoi230477r4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1377\/hlthaff.2016.0286","article-title":"New anticancer drugs associated with large increases in costs and life expectancy.","volume":"35","author":"Howard","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"zoi230477r5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jhealeco.2010.02.006","article-title":"An economic evaluation of the war on cancer.","volume":"29","author":"Lakdawalla","year":"2010","journal-title":"J Health Econ"},{"issue":"1","key":"zoi230477r6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1515\/fhep-2015-0028","article-title":"Quantifying gains in the war on cancer due to improved treatment and earlier detection.","volume":"19","author":"Seabury","year":"2016","journal-title":"Forum Health Econ Policy"},{"issue":"2","key":"zoi230477r7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1558-9544.1195","article-title":"The contributions of improved therapy and earlier detection to cancer survival gains, 1988-2000.","volume":"13","author":"Sun","year":"2010","journal-title":"Forum Health Econ Policy"},{"issue":"4","key":"zoi230477r8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1377\/hlthaff.2011.1298","article-title":"An analysis of whether higher health care spending in the United States versus Europe is \u2018worth it\u2019 in the case of cancer.","volume":"31","author":"Philipson","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"zoi230477r9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s001480050104","article-title":"Income and employment effects of health shocks: a test case for the German welfare state.","volume":"12","author":"Riphahn","year":"1999","journal-title":"J Popul Econ"},{"issue":"2","key":"zoi230477r10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1257\/jep.13.2.145","article-title":"Healthy bodies and thick wallets: the dual relation between health and economic status.","volume":"13","author":"Smith","year":"1999","journal-title":"J Econ Perspect"},{"issue":"4","key":"zoi230477r11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jhealeco.2005.05.004","article-title":"Ill health and retirement in Britain: a panel data-based analysis.","volume":"25","author":"Disney","year":"2006","journal-title":"J Health Econ"},{"issue":"7","key":"zoi230477r12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jama.2009.187","article-title":"Cancer survivors and unemployment: a meta-analysis and meta-regression.","volume":"301","author":"de Boer","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"zoi230477r13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hec.v26.5","article-title":"The long-term effects of cancer on employment and earnings.","volume":"26","author":"Jeon","year":"2017","journal-title":"Health Econ"},{"issue":"24","key":"zoi230477r14","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1002\/cncr.29510","article-title":"Employment and income losses among cancer survivors: Estimates from a national longitudinal survey of American families.","volume":"121","author":"Zajacova","year":"2015","journal-title":"Cancer"},{"issue":"30","key":"zoi230477r16","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1200\/JCO.2013.49.1241","article-title":"Economic burden of cancer survivorship among adults in the United States.","volume":"31","author":"Guy","year":"2013","journal-title":"J Clin Oncol"},{"key":"zoi230477r17","doi-asserted-by":"publisher","DOI":"10.1177\/0046958019880696","article-title":"Health care expenditure burden of cancer care in the United States.","volume":"56","author":"Park","year":"2019","journal-title":"Inquiry"},{"issue":"4","key":"zoi230477r20","doi-asserted-by":"publisher","DOI":"10.5600\/mmrr","article-title":"Reconciling medical expenditure estimates from the MEPS and NHEA, 2007.","volume":"2","author":"Bernard","year":"2012","journal-title":"Medicare Medicaid Res Rev"},{"issue":"1","key":"zoi230477r22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1536867X1501500102","article-title":"twopm: Two-part models.","volume":"15","author":"Belotti","year":"2015","journal-title":"Stata J"},{"issue":"16","key":"zoi230477r25","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJM199910143411606","article-title":"Racial differences in the treatment of early-stage lung cancer.","volume":"341","author":"Bach","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi230477r26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2105\/AJPH.2011.300550","article-title":"Racial differences in breast cancer stage at diagnosis in the mammography era.","volume":"103","author":"Chatterjee","year":"2013","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi230477r27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3322\/caac.v66.4","article-title":"Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities.","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"zoi230477r29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11113-016-9416-y","article-title":"Racial and ethnic disparities in health insurance coverage: dynamics of gaining and losing coverage over the life-course.","volume":"36","author":"Sohn","year":"2017","journal-title":"Popul Res Policy Rev"},{"issue":"Suppl 1","key":"zoi230477r30","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.2105\/AJPH.2009.166082","article-title":"Socioeconomic disparities in health in the United States: what the patterns tell us.","volume":"100","author":"Braveman","year":"2010","journal-title":"Am J Public Health"},{"issue":"Suppl 1","key":"zoi230477r31","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.2105\/AJPH.2010.300058","article-title":"Environmental health disparities in housing.","volume":"101","author":"Jacobs","year":"2011","journal-title":"Am J Public Health"},{"issue":"1","key":"zoi230477r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29238","article-title":"Assessment of racial disparities in primary care physician specialty referrals.","volume":"4","author":"Landon","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi230477r33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaoncol.2021.1322","article-title":"The need for critical examination of disparities in immunotherapy and targeted therapy use among patients with cancer.","volume":"7","author":"Ashrafzadeh","year":"2021","journal-title":"JAMA Oncol"},{"issue":"7","key":"zoi230477r34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.22009","article-title":"Racial and ethnic disparities in cancer care during the COVID-19 pandemic.","volume":"5","author":"Patel","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi230477r35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55388","article-title":"Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis.","volume":"6","author":"Ehsan","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi230477r36","first-page":"188","article-title":"The well-being of long-term cancer survivors.","volume":"24","author":"Sullivan","year":"2018","journal-title":"Am J Manag Care"},{"key":"zoi230477r37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/PGPM.S310345","article-title":"The help of HPV integration testing to avoid the misdiagnosis of a patient with stage IA1 cervical cancer: a case report and literature review.","volume":"14","author":"Li","year":"2021","journal-title":"Pharmgenomics Pers Med"},{"key":"zoi230477r24","author":"Cong"},{"key":"zoi230477r2","unstructured":"The White House. Fact sheet: President Biden reignites cancer moonshot to end cancer as we know it. February 2, 2022. Accessed April 22, 2023. https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2022\/02\/02\/fact-sheet-president-biden-reignites-cancer-moonshot-to-end-cancer-as-we-know-it\/"},{"key":"zoi230477r15","unstructured":"National Cancer Institute. Financial burden of cancer care. Accessed May 13, 2022. https:\/\/progressreport.cancer.gov\/after\/economic_burden"},{"key":"zoi230477r18","unstructured":"Social Security Administration. Annual statistical report on the Social Security Disability Insurance Program, 2020. Accessed April 22, 2023. https:\/\/www.ssa.gov\/policy\/docs\/statcomps\/di_asr\/2020\/index.html"},{"key":"zoi230477r19","unstructured":"Center on Budget and Policy Priorities. Chart book: Social Security Disability Insurance. 2021. Accessed April 22, 2023. https:\/\/www.cbpp.org\/research\/social-security\/social-security-disability-insurance-0"},{"key":"zoi230477r21","unstructured":"Bureau of Labor Statistics. Data comparisons. Accessed March 31, 2023. https:\/\/www.bls.gov\/cex\/cecomparison\/meps_profile.htm"},{"key":"zoi230477r23","unstructured":"American Cancer Society. Cancer facts & figures 2022. April 22, 2023. https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2022\/2022-cancer-facts-and-figures.pdf"},{"key":"zoi230477r28","unstructured":"American Association for Cancer Research. AACR cancer disparities progress report 2022. April 13, 2023. http:\/\/www.CancerDisparitiesProgressReport.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805325\/grabowski_2023_oi_230477_1684340578.51298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:31:50Z","timestamp":1685115110000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.15823","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]}}}